Liver cell transplantation leads to repopulation and functional correction in a mouse model of Wilson's disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 11, 2004, Pages 1283-1290

  Allen, Katrina J ^a,d   Cheah, Daphne M Y ^a   Wright, Paul F A ^b   Gazeas, Sophie ^a   Pettigrew Buck, Nicole E ^a   Deal, Yolanda H ^c   Mercer, Julian F B ^c   Williamson, Robert ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b RMIT UNIVERSITY   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Copper; Liver cell therapy; Toxic milk mouse; Transplantation; Wilson's disease

Indexed keywords

CERULOPLASMIN; COPPER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL RENEWAL; CELL TRANSPLANTATION; CONTROLLED STUDY; COPPER METABOLISM; LIVER CELL; LIVER FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; WILSON DISEASE;

EID: 8344277995     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2004.03451.x     Document Type: Article

References (22)

1. Strom S, Fisher RA, Thompson MT et al. Human hepatocyte transplantation. In: Mito M, Sawa M, eds. Hepatocyte Transplantation. Basel: Karger Landes System, 1997; 325-41.
2. Fox IJ, Roy Chowdhury J et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 1998; 338: 1422-6.
3. Horslen SP, McCowan TC, Goertzen TC et al. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 2003; 111: 1262-7.
4. Overturf K, Al-Dhalimy M, Tanguay R et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat. Genet. 1996; 12: 266-73.
5. de Vree JML, Ottenhoff R, Bosma PJ, Smith AJ, Aten J, Oude Elferink P. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 2000; 119: 1720-30.
6. Laconi E, Oran R, Mukhopadhyay DK et al. Long-term, near total liver repopulation by transplantation of isolated hepatocytes in rats treated with retrorsine. Am. J. Pathol. 1998; 153: 319-29.
7. Irani AN, Malhi H, Slehria S et al. Correction of liver disease following transplantation of normal rat hepatocytes into Long-Evans Cinnamon rats modeling Wilson's disease. Mol. Ther. 2001; 3: 302-9.
8. Rauch H. Toxic milk, a new mutation affecting copper metabolism in the mouse. J. Hered. 1983; 74: 141-4.
9. Theophilos MB, Cox DW, Mercer JFB. The toxic milk mouse is a murine model of Wilson disease. Hum. Mol. Genet. 1996; 5: 1619-24.
10. La Fontaine S, Theophilos MB, Firth SD, Gould R, Parton RG, Mercer JFB. Effect of the toxic milk mutation (tx) on the function and intracellular localization of Wnd, the murine homologue of the Wilson copper ATPase. Hum. Mol. Genet. 2001; 10: 361-70.
11. Schaefer M, Hopkins RG, Failla ML, Gitlin JD. Hepatocyte-specific localization and copper-dependent trafficking of the Wilson's disease protein in the liver. Am. J. Physiol. Gastrointest. Liver Physiol. 1999; 39: G639-G46.
12. Yoshida Y, Tokusashi Y, Lee G-H, Ogawa K. Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans Cinnamon rats. Gastroenterology 1996; 111: 1654-60.
13. Allen KJ, Soriano HE. Liver cell transplantation: the road to clinical application. J. Lab. Clin. Med. 2001; 138: 298-312.
14. Seglen PO. Preparation of rat liver cells: III enzymatic requirements for tissue dispersion. Exp. Cell Res. 1973; 82: 391-8.
15. Strauss MW. Preparation of genomic DNA from mammalian tissue. In: Ausubel FM, Brent R, Kingston RE et al., eds. Current Protocols in Molecular Biology, Vol. 1. Canada: John Wiley & Sons, 1998; 2.2.1-2.2.3.
16. Michalczyk AA, Rieger J, Allen KJ, Mercer JFB, Ackland ML. Defective localization of the Wilson disease protein (ATP7B) in the mammary gland of the toxic milk mouse and the effects of copper supplementation. Biochem. J. 2000; 352: 565-71.
17. Schosinsky KH, Lehmann HP, Beeler MF. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin. Chem. 1974; 20: 1556-63.
18. Wu J-C, Huang C-C, Jeng L-B, Chu N-S. Correlation of neurological manifestations and MR images in a patient with Wilson's disease after liver transplantation. Acta Neurol. Scand. 2000; 102: 135-9.
19. Lingam S, Wilson J, Nazer H, Mowat AP. Neurological abnormalities in Wilson's disease are reversible. Neuropediatrics 1987; 18: 11-12.
20. Malhi H, Irani AN, Volenberg I, Schilsky ML, Gupta S. Early cell transplantation in LEG rats modeling Wilson's disease eliminates hepatic copper with reversal of liver disease. Gastroenterology 2002; 122: 438-47.
21. Braun KM, Degen JL, Sandgren EP. Hepatocyte transplantation in a model of toxin-induced liver disease: variable therapeutic effect during replacement of damaged parenchyma by donor cells. Nat. Med. 2000; 6: 320-6.
22. Overturf K, Al-Dhalimy M, Ou C-N, Finegold M, Grompe M. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am. J. Pathol. 1997; 151: 1273-80.